Ergothioneine and melatonin attenuate oxidative stress and protect against learning and memory deficits in C57BL/6J mice treated with D-galactose

Free Radical Research

Volumn 48, Issue 9, 2014, Pages 1049-1060

  Song, T Y ^a   Lin, H C ^a   Chen, C L ^a   Wu, J H ^b   Liao, J W ^b   Hu, M L ^b  

^a CHUNG CHOU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Alzheimer's disease; D galactose; Ergothioneine; Learning and memory; Melatonin

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; GALACTOSE; GLUTATHIONE; GLUTATHIONE DISULFIDE; MELATONIN; SUPEROXIDE DISMUTASE; THIONEINE; ANTIOXIDANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AVOIDANCE BEHAVIOR; BIOACCUMULATION; BRAIN TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; LATENT PERIOD; LEARNING; LEARNING DISORDER; LIPID PEROXIDATION; MALE; MEMORY; MEMORY DISORDER; MORRIS WATER MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; TASK PERFORMANCE; ALZHEIMER DISEASE; ANIMAL; BRAIN; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; MAZE TEST; METABOLISM; PATHOLOGY;

ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; ERGOTHIONEINE; GALACTOSE; IMMUNOHISTOCHEMISTRY; MALE; MAZE LEARNING; MELATONIN; MEMORY; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS;

EID: 84906058399     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2014.920954     Document Type: Conference Paper

References (54)

1. Jewart RD, Green J, Lu CJ, Cellar J, Tune LE. Cognitive, behavioral, and physiological changes in Alzheimer disease patients as a function of incontinence medications. Am J Geriatr Psychiatry 2005 13 324-328
2. Arendash GW, Schleif W, Reazi-zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, et al. Caff eine protects Alzheimer 's mice against cognitive impairment and reduces brain-beta amyloid production. Neuroscience 2006 142 941-952
3. Butterfi eld DA, Shelley TR, Newman F, Sultana R. Roles of amyloid βpeptide-Associated oxidative stress and brain protein modifi cations in the pathogenesis of Alzheimer 's disease and mild cognitive impairment. Free Radic Biol Med 2007 43 658-677
4. Rammouz G, Lecanu L, Aisen P, Papadopoulos V. A lead study on oxidative stress-mediated dehydroepiandrosterone formation in serum: The biochemical basis for a diagnosis of Alzheimer 's disease. J Alzheimers Dis 2011 24 5-16
5. Schubert D, Behl C, Lesley R, Brack A, Dargusch R, Sagara Y, Kimura H. Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci U S A 1995 92 1989-1993
6. Townsend KP, Pratico D. Novel therapeutic opportunities for Alzheimer 's disease: Focus on nonsteroidal anti-infl ammatory drugs. FASEB J 2005 19 1592-1601
7. Butterfi eld DA, Boyd-Kimball D. Amyloid beta-peptide (1 - 42) contributes to the oxidative stress and neurodegeneration found in Alzheimer 's disease brain. Brain Pathol 2004; 14: 426-432
8. Melville DB, Horner WH, Otken CC, Ludwig ML. Studies on the origin of ergothioneine in animals. J Biol Chem 1955 213 61-68
9. Nakamichi N, Taguchi T, Hosotani H, Wakayama T, Shimizu T, Sugiura T, et al. Functional expression of carnitine/organic cation transporter OCTN1 in mouse brain neurons: Possible involvement in neuronal diff erentiation. Neurochem Int 2012 61 1121-1132
10. Aruoma OI, Whiteman M, England TG, Halliwell B. Antioxidant action of ergothioneine: Assessment of its ability to scavenge peroxynitrite. Biochem Biophys Res Commun 1997 231 389-391
11. Cheah IK, Halliwell B. Ergothioneine; antioxidant potential, physiological function and role in Disease. Biochim Biophys Acta 2012 1822 784-793
12. Moncaster JA, Walsh DT, Gentleman SM, Jen LS, Aruoma OI. Ergothioneine treatment protects neurons against N-methyl-D-Aspartate excitotoxicity in an in vivo rat retinal model. Neurosci Lett 2002 328 55-59
13. Jang JH, Aruoma OI, Jen LS, Chung HY, Surh YJ. Ergothioneine rescues PC12 cells from b-Amyloid-induced apoptotic death. Free Radic Biol Med 2004; 36: 288-299
14. Song TY, Chen CL, Liao JW, Ou HC, Tsai MS. Ergothioneine protects against neuronal injury induced by cisplatin both in vitro and in vivo. Food Chem Toxicol 2010 48 3492-3499
15. Aruoma OI, Spencer JP, Mahmood N. Protection against oxidative damage and cell death by the natural antioxidant ergothioneine. Food Chem Toxicol 1999; 37: 1043-1053
16. Tan DX, Chen D, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: A potent endogenous hydroxyl radical scavenger. Endocrinol J 1993 1 57-60
17. Tan DX, Hardeland R, Manchester LC, Poeggeler B, Lopez- Burillo S, Mayo JC, et al. Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical. J Pineal Res 2003 34 249-259
18. Liu RY, Zhou JN, van Heerikhuize J, Hofman MA, Swaab DF. Decreased melatonin levels in postmortem cerebrospinal fl uid in relation to aging, Alzheimer 's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metab 1999 84 323-327
19. Ozcankaya R, Delibas N. Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: Cross-sectional study. Croat Med J 2002 43 28-32
20. Rosales-Corral SA, Acuña-Castroviejo D, Coto-Montes A, Boga JA, Manchester LC, Fuentes-Broto L, et al. Alzheimer 's disease: Pathological mechanisms and the benefi cial role of melatonin. J Pineal Res 2012 52 167-202
21. Yang NC, Lin HC, Wu JH, Ou HC, Chai YC, Tseng CY, et al. Ergothioneine protects against neuronal injury induced by β-Amyloid in mice. Food Chem Toxicol 2012; 50: 3902-3911
22. Holden HM, Rayment I, Thoden JB. Structure and function of enzymes of the Leloir pathway for galactose metabolism. J Biol Chem 2003 278 43885-43888
23. Cui X, Wang L, Zuo P, Han Z, Fang Z, Li W, Liu J. D-Galactose-caused life shortening in Drosophila melanogaster and Musca domestica is associated with oxidative stress. Biogerontology 2004; 5: 317-326
24. Deng H, Cui D, Jiang J, Feng Y, Cai N, Li D. Inhibiting eff ects of Achyranthes bidentata polysaccharide and Lycium barbarum polysaccharide on nonenzyme glycation in D-galactose induced mouse aging model. Biomed Environ Sci 2003 16 267-275
25. Zhang Q, Li X, Cui X, Zuo P. D-Galactose injured neurogenesis in the hippocampus of adult mice. Neurol Res 2005 27 552-556
26. Lei H, Wang B, Li W, Yang Y, Zhou A, Chen M. Anti-Aging eff ect of astragalosides and its mechanism of action. Acta Pharmacol Sin 2003 24 230-234
27. Song X, Bao MM, Li DD, Li YM. Advanced glycation in D-galactose induced mouse aging model. Mech Ageing Dev 1999 108 239-251
28. Ho SC, Liu JH, Wu RY. Establishment of the mimetic aging eff ect in mice caused by D-galactose. Biogerontology 2003 4 15-18
29. Lei M, Hua X, Xiao M, Ding J, Han Q, Hu G. Impairments of astrocytes are involved in the D-galactose-induced brain aging. Biochem Biophys Res Commun 2008 369 1082-1087
30. Hsieh HM, Wu WM, Hu ML. Soy isofl avones attenuate oxidative stress and improve parameters related to aging and Alzheimer 's disease in C57BL/6J mice treated with D-galactose. Food Chem Toxicol 2009; 47: 625-632
31. Anand KV, Mohamed SMJ, Thomas PA, Geraldine P. Protective role of chrysin against oxidative stress in D-galactoseinduced aging in an experimental rat model. Geriatr Gerontol Int 2012 12 741-750
32. Cambell MD, Jaques Jr S, Gala RR. The lack of an eff ect of cholinergic agonists on anterior pituitary prolactin production in vitro. Experientia 1978 34 1522-1523
33. Doody RS. Clinical profi le of donepezil in the treatment of Alzheimer 's disease. Gerontology 1999 45 23-32
34. Lee CL, Kuo TF, Wang JJ, Pan TM. Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid β-infused rat by repressing amyloid -Accumulation. J Neurosci Res 2007 85 3171-3182
35. Schofi eld JD, Chen X. Analysis of free reduced and free oxidized glutathione in wheat fl our. J Cereal Sci 1995; 21: 127-136
36. Buege AJ, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978 52 302-310
37. Ellman GL, Courtney KD, Andres VJ, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961 7 88-95
38. Dubost NJ, Beelman R, Peterson D, Royse D. Identifi cation and quantifi cation of ergothioneine in cultivated mushrooms using liquid chromatography-mass spectroscopy. Int J Med Mushr 2007 8 215-222
39. Liu YY, Nagpure BV, Wong PT, Bian JS. Hydrogen sulfi de protects SH-SY5Y neuronal cells against d-galactose induced cell injury by suppression of advanced glycation end products formation and oxidative stress. Neurochem Int 2013 62 603-609
40. Chen B, Zhong Y, Peng W, Sun Y, Hu YJ, et al. Increased mitochondrial DNA damage and decreased base excision repair in the auditory cortex of D-galactose-induced aging rats. Mol Biol Rep 2011 38 3635-3642
41. Borza LR. A review on the cause-eff ect relationship between oxidative stress and toxic proteins in the pathogenesis of neurodegenerative diseases. Rev Med Chir Soc Med Nat Iasi 2014 118 19-27
42. D 'Hooge R, De Deyn PP. Applications of the Morris water maze in the study of learning and memory. Brain Res Rev 2001 36 60-90
43. Li XM, Ma YL, Liu XJ. Eff ect of the Lycium barbarum polysaccharides on age-related oxidative stress in aged mice. J Ethnopharmacol 2007 111 504-511
44. Rogers JL, Kesner RP. Cholinergic modulation of the hippocampus during encoding and retrieval. Neurobiol Learn Mem 2003 80 332-342
45. Ulrich J, Meier-Ruge W, Probst A, Meier E, Ipsen S. Senile plaques: Staining for acetylcholinesterase and A4 protein: A comparative study in the hippocampus and entorhinal cortex. Acta Neuropathol 1990 80 624-628
46. Morán MA, Mufson EJ, Gómez-Ramos P. Colocalization of cholinesterases with βamyloid protein in aged and Alzheimer 's brains. Acta Neuropathol 1993 85 362-369
47. Inestrosa NC, Alvarez A, Pérez CA, Moreno RD, Vicente M, Linker C, et al. Acetylcholinesterase accelerates assembly of amyloid β-peptides into Alzheimer 's fi brils: Possible role of the peripheral site of the enzyme. J Neuron 1996 16 881-891
48. Alvarez A, Alarcon R, Opazo C, Campos EO, Munoz FJ, Calderon FH, et al. Stable complexes involving acetylcholinesterase and amyloid-βpeptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer 's fi brils. J Neurosci 1998 18 3213-3223
49. Kaizer RR, Corrêa MC, Spanevello RM, Morsch VM, Mazzanti CM, Gonçalves JF, Schetinger MR. Acetylcholinesterase activation and enhanced lipid peroxidation after long-Term exposure to low levels of aluminum on Diff erent mouse brain regions. J Inorg Biochem 2005; 99: 1865-1870
50. Lamhonwah AM, Hawkins CE, Tam C, Wong J, Mai L, Tein I. Expression patterns of the organic cation/carnitine transporter family in adult murine brain. Brain Dev 2008; 30: 31-42
51. Sugiura T, Kato S, Shimizu T, Wakayama T, Nakamichi N, Kubo Y, et al. Functional expression of carnitine/organic cation transporter OCTN1/SLC22A4 in mouse small intestine and liver. Drug Metab Dispos 2010 38 1665-1672
52. Kato Y, Kubo Y, Iwata D, Kato S, Sudo T, Sugiura T, et al. Gene knockout and metabolome analysis of carnitine/organic cation transporter OCTN1. Pharm Res 2010 27 832-840
53. Gründemann D, Stephanie H, Golz S, Geerts A, Lazar A, Berkels R, et al. Discovery of the ergothioneine transporter. Proc Natl Acad Sci USA 2005 102 5256-5261
54. Parle M, Dhingra D, Kulkarni SK. Neurochemical basis of learning and memory. Ind J Pharm Sci 2004 66 371-376.